Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) Clinical Trials in Los Angeles, California

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma